{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:11:26Z","timestamp":1793373086708,"version":"4.5.0"},"reference-count":138,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2021,5,26]]},"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The clinical context for using blood eosinophil (EOS) counts as treatment\u2013response biomarkers in asthma and COPD requires better understanding of EOS distributions and ranges. We describe EOS distributions and ranges published in asthma, COPD, control (non-asthma\/COPD) and general populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a comprehensive literature review and meta-analysis of observational studies (January 2008 to November 2018) that included EOS counts in asthma, severe asthma, COPD, control and general populations. Excluded studies had total sample sizes &lt;200, EOS as inclusion criterion, hospitalised population only and exclusively paediatric participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, 91 eligible studies were identified, most had total-population-level data available: asthma (39 studies), severe asthma (12 studies), COPD (23 studies), control (seven studies) and general populations (14 studies); some articles reported data for multiple populations. Reported EOS distributions were right-skewed (seven studies). Reported median EOS counts ranged from 157\u2013280\u2005cells\u00b7\u00b5L\n                      <jats:sup>\u22121<\/jats:sup>\n                      (asthma, 22 studies); 200\u2013400\u2005cells\u00b7\u00b5L\n                      <jats:sup>\u22121<\/jats:sup>\n                      (severe asthma, eight studies); 150\u2013183\u2005cells\u00b7\u00b5L\n                      <jats:sup>\u22121<\/jats:sup>\n                      (COPD, six studies); and 100\u2013160\u2005cells\u00b7\u00b5L\n                      <jats:sup>\u22121<\/jats:sup>\n                      (controls, three studies); and 100\u2013200\u2005cells\u00b7\u00b5L\n                      <jats:sup>\u22121<\/jats:sup>\n                      (general populations, six studies). The meta-analysis showed that observed variability was mostly between studies rather than within studies. Factors reportedly associated with higher blood EOS counts included current smoking, positive skin-prick test, elevated total IgE, comorbid allergic rhinitis, age \u226418\u2005years, male sex, spirometric asthma\/COPD diagnosis, metabolic syndrome and adiposity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>EOS distribution and range varied by study population, and were affected by clinical factors including age, smoking history and comorbidities, which, regardless of severity, should be considered during treatment decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/13993003.04590-2020","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T12:05:17Z","timestamp":1624622717000},"page":"2004590","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":101,"title":["Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis"],"prefix":"10.1183","volume":"59","author":[{"given":"Victoria S.","family":"Benson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0734-0070","authenticated-orcid":false,"given":"Sylvia","family":"Hartl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Galwey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7246-2093","authenticated-orcid":false,"given":"Melissa K.","family":"Van Dyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namhee","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2021,6,25]]},"reference":[{"key":"2024102102313134000_59.1.2004590.1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD) . Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2021 Report. https:\/\/goldcopd.org\/wp-content\/uploads\/2020\/11\/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf"},{"key":"2024102102313134000_59.1.2004590.2","unstructured":"Global Initiative for Asthma (GINA) . Global Strategy for Asthma Management and Prevention. 2020 Report. https:\/\/ginasthma.org\/wp-content\/uploads\/2020\/04\/GINA-2020-full-report_-final-_wms.pdf"},{"key":"2024102102313134000_59.1.2004590.3","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.153.2.8564092"},{"key":"2024102102313134000_59.1.2004590.4","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2004.032516"},{"key":"2024102102313134000_59.1.2004590.5","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201108-1553OC"},{"key":"2024102102313134000_59.1.2004590.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403290"},{"key":"2024102102313134000_59.1.2004590.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708208"},{"key":"2024102102313134000_59.1.2004590.8","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMoa1905248","article-title":"Benralizumab for the prevention of COPD exacerbations","volume":"381","author":"Criner","year":"2019","journal-title":"N Engl J Med"},{"key":"2024102102313134000_59.1.2004590.9","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207021"},{"key":"2024102102313134000_59.1.2004590.10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2213-2600(15)00106-X","article-title":"Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials","volume":"3","author":"Pascoe","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2024102102313134000_59.1.2004590.11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201502-0235LE"},{"key":"2024102102313134000_59.1.2004590.12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S2213-2600(18)30327-8","article-title":"Triple therapy with budesonide\/glycopyrrolate\/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial","volume":"6","author":"Ferguson","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2024102102313134000_59.1.2004590.13","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201103-0396OC"},{"key":"2024102102313134000_59.1.2004590.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60988-X"},{"key":"2024102102313134000_59.1.2004590.15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S2213-2600(15)00042-9","article-title":"Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"3","author":"Castro","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2024102102313134000_59.1.2004590.16","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S2213-2600(16)00100-4","article-title":"Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial","volume":"4","author":"Watz","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2024102102313134000_59.1.2004590.17","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1164\/rccm.201612-2525LE","article-title":"Eosinophilia, frequent exacerbations, and steroid response in chronic obstructive pulmonary disease","volume":"196","author":"Calverley","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102102313134000_59.1.2004590.18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-2600(18)30006-7","article-title":"Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials","volume":"6","author":"Bafadhel","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2024102102313134000_59.1.2004590.19","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S2213-2600(18)30137-1","article-title":"The association between blood eosinophils and risk and treatment outcome in COPD is not dichotomised","volume":"6","author":"Pascoe","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2024102102313134000_59.1.2004590.20","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200711-1754OC"},{"key":"2024102102313134000_59.1.2004590.21","doi-asserted-by":"publisher","DOI":"10.1111\/all.12345"},{"key":"2024102102313134000_59.1.2004590.22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.pmedr.2016.08.009","article-title":"Current cigarette smoking is a reversible cause of elevated white blood cell count: cross-sectional and longitudinal studies","volume":"4","author":"Higuchi","year":"2016","journal-title":"Prev Med Rep"},{"key":"2024102102313134000_59.1.2004590.23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01874-2019"},{"key":"2024102102313134000_59.1.2004590.24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535"},{"key":"2024102102313134000_59.1.2004590.25","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00202013"},{"key":"2024102102313134000_59.1.2004590.26","doi-asserted-by":"crossref","first-page":"100119","DOI":"10.1016\/j.waojou.2020.100119","article-title":"Factors that affect blood eosinophil counts in a non-asthmatic population: post hoc analysis of data from Brazil","volume":"13","author":"Kwon","year":"2020","journal-title":"World Allergy Organ J"},{"key":"2024102102313134000_59.1.2004590.27","doi-asserted-by":"crossref","first-page":"1458560","DOI":"10.1080\/20018525.2018.1458560","article-title":"Health care resource utilization and characteristics of patients with eosinophilic asthma in secondary health care in Finland","volume":"5","author":"M\u00e4kel\u00e4","year":"2018","journal-title":"Eur Clin Respir J"},{"key":"2024102102313134000_59.1.2004590.28","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"2024102102313134000_59.1.2004590.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.06.007"},{"key":"2024102102313134000_59.1.2004590.30","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/cea.13103","article-title":"The absence of serum IgE antibodies indicates non-type 2 disease in young asthmatics","volume":"48","author":"Tsolakis","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"2024102102313134000_59.1.2004590.31","doi-asserted-by":"crossref","first-page":"e0124675","DOI":"10.1371\/journal.pone.0124675","article-title":"Perceived food hypersensitivity relates to poor asthma control and quality of life in young non-atopic asthmatics","volume":"10","author":"Johnson","year":"2015","journal-title":"PLoS One"},{"key":"2024102102313134000_59.1.2004590.32","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7155\/8\/2\/026002"},{"key":"2024102102313134000_59.1.2004590.33","doi-asserted-by":"publisher","DOI":"10.1111\/all.12430"},{"key":"2024102102313134000_59.1.2004590.34","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jaip.2017.02.001","article-title":"Diagnostic accuracy of inflammatory markers for diagnosing occupational asthma","volume":"5","author":"Racine","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102102313134000_59.1.2004590.35","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1164\/rccm.201602-0419OC","article-title":"Inflammatory and comorbid features of patients with severe asthma and frequent exacerbations","volume":"195","author":"Denlinger","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102102313134000_59.1.2004590.36","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-208178"},{"key":"2024102102313134000_59.1.2004590.37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12890-016-0208-2","article-title":"Detailed analysis of sputum and systemic inflammation in asthma phenotypes: are paucigranulocytic asthmatics really non-inflammatory?","volume":"16","author":"Demarche","year":"2016","journal-title":"BMC Pulm Med"},{"key":"2024102102313134000_59.1.2004590.38","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-13-11"},{"key":"2024102102313134000_59.1.2004590.39","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00779-2015"},{"key":"2024102102313134000_59.1.2004590.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.12.1574"},{"key":"2024102102313134000_59.1.2004590.41","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00616-2018"},{"key":"2024102102313134000_59.1.2004590.42","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2014.6.1.55"},{"key":"2024102102313134000_59.1.2004590.43","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1165\/rcmb.2017-0373OC","article-title":"Systemic markers of adaptive and innate immunity are associated with chronic obstructive pulmonary disease severity and spirometric disease progression","volume":"58","author":"Halper-Stromberg","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2024102102313134000_59.1.2004590.44","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01162-2017"},{"key":"2024102102313134000_59.1.2004590.45","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jaip.2017.05.032","article-title":"Baseline features of the Severe Asthma Research Program (SARP III) cohort: differences with age","volume":"6","author":"Teague","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102102313134000_59.1.2004590.46","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/cea.12897","article-title":"The sensitization pattern differs according to rhinitis and asthma multimorbidity in adults: the EGEA study","volume":"47","author":"Burte","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"2024102102313134000_59.1.2004590.47","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2016.267450"},{"key":"2024102102313134000_59.1.2004590.48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036672"},{"key":"2024102102313134000_59.1.2004590.49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.rmed.2018.10.025","article-title":"Eosinophilic asthma, according to a blood eosinophil criterion, is associated with disease severity and lack of control among underprivileged urban Brazilians","volume":"145","author":"Lima-Matos","year":"2018","journal-title":"Respir Med"},{"key":"2024102102313134000_59.1.2004590.50","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00019-2017"},{"key":"2024102102313134000_59.1.2004590.51","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00201813"},{"key":"2024102102313134000_59.1.2004590.52","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/15412555.2018.1441275","article-title":"Demographic and clinical characteristics of COPD patients at different blood eosinophil levels in the UK Clinical Practice Research Datalink","volume":"15","author":"Landis","year":"2018","journal-title":"COPD"},{"key":"2024102102313134000_59.1.2004590.53","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.2147\/COPD.S167379","article-title":"Health characteristics of patients with asthma, COPD and asthma-COPD overlap in the NHANES database","volume":"13","author":"Llanos","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024102102313134000_59.1.2004590.54","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.rmed.2016.01.013","article-title":"Relationship between blood eosinophils and clinical characteristics in a cross-sectional study of a US population-based COPD cohort","volume":"112","author":"DiSantostefano","year":"2016","journal-title":"Respir Med"},{"key":"2024102102313134000_59.1.2004590.55","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201509-1869OC"},{"key":"2024102102313134000_59.1.2004590.56","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1164\/rccm.201701-0009LE","article-title":"Stability of blood eosinophils in patients with chronic obstructive pulmonary disease and in control subjects, and the impact of sex, age, smoking, and baseline counts","volume":"195","author":"Oshagbemi","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102102313134000_59.1.2004590.57","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.rmed.2017.03.002","article-title":"Serum cytokine profiles as predictors of asthma control in adults from the EGEA study","volume":"125","author":"Akiki","year":"2017","journal-title":"Respir Med"},{"key":"2024102102313134000_59.1.2004590.58","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00336-2016"},{"key":"2024102102313134000_59.1.2004590.59","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2008.103069"},{"key":"2024102102313134000_59.1.2004590.60","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13601-018-0201-3","article-title":"Having concomitant asthma phenotypes is common and independently relates to poor lung function in NHANES 2007-2012","volume":"8","author":"Amaral","year":"2018","journal-title":"Clin Transl Allergy"},{"key":"2024102102313134000_59.1.2004590.61","doi-asserted-by":"crossref","first-page":"026012","DOI":"10.1088\/1752-7163\/aa9c86","article-title":"Biomarkers related to respiratory symptoms and lung function in adults with asthma","volume":"12","author":"Calciano","year":"2018","journal-title":"J Breath Res"},{"key":"2024102102313134000_59.1.2004590.62","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5603\/ARM.2017.0031","article-title":"Exhaled nitric oxide atopy, and spirometry in asthma and rhinitis patients in India","volume":"85","author":"Kumar","year":"2017","journal-title":"Adv Respir Med"},{"key":"2024102102313134000_59.1.2004590.63","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jaip.2018.03.004","article-title":"Type 2 biomarkers and prediction of future exacerbations and lung function decline in adult asthma","volume":"6","author":"Semprini","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102102313134000_59.1.2004590.64","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3904\/kjim.2017.043","article-title":"Methacholine bronchial provocation test in patients with asthma: serial measurements and clinical significance","volume":"33","author":"Seo","year":"2018","journal-title":"Korean J Intern Med"},{"key":"2024102102313134000_59.1.2004590.65","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.rmed.2016.06.017","article-title":"A 12-year prognosis of adult-onset asthma: Sein\u00e4joki Adult Asthma Study","volume":"117","author":"Tuomisto","year":"2016","journal-title":"Respir Med"},{"key":"2024102102313134000_59.1.2004590.66","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00012415"},{"key":"2024102102313134000_59.1.2004590.67","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12214"},{"key":"2024102102313134000_59.1.2004590.68","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1378\/chest.12-2289","article-title":"Long-term mortality among adults with asthma: a 25-year follow-up of 1,075 outpatients with asthma","volume":"143","author":"Ali","year":"2013","journal-title":"Chest"},{"key":"2024102102313134000_59.1.2004590.69","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.rmed.2013.07.016","article-title":"Differences between asthma in young and elderly: results from the COREA study","volume":"107","author":"Park","year":"2013","journal-title":"Respir Med"},{"key":"2024102102313134000_59.1.2004590.70","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2222.2011.03945.x","article-title":"Associated demographics of persistent exhaled nitric oxide elevation in treated asthmatics","volume":"42","author":"Matsunaga","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"2024102102313134000_59.1.2004590.71","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.rmed.2017.12.001","article-title":"A retrospective cohort study in severe asthma describing commonly measured biomarkers: eosinophil count and IgE levels","volume":"134","author":"Haughney","year":"2018","journal-title":"Respir Med"},{"key":"2024102102313134000_59.1.2004590.72","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/all.13342","article-title":"RItA: the Italian severe\/uncontrolled asthma registry","volume":"73","author":"Maio","year":"2018","journal-title":"Allergy"},{"key":"2024102102313134000_59.1.2004590.73","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.rmed.2016.07.005","article-title":"Effects of older age and age of asthma onset on clinical and inflammatory variables in severe refractory asthma","volume":"118","author":"Chaudhuri","year":"2016","journal-title":"Respir Med"},{"key":"2024102102313134000_59.1.2004590.74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102987"},{"key":"2024102102313134000_59.1.2004590.75","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12931-018-0767-2","article-title":"Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD)","volume":"19","author":"Chalmers","year":"2018","journal-title":"Respir Res"},{"key":"2024102102313134000_59.1.2004590.76","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2147\/COPD.S165909","article-title":"Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort","volume":"13","author":"Greulich","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024102102313134000_59.1.2004590.77","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12931-018-0840-x","article-title":"Serial blood eosinophils and clinical outcome in patients with chronic obstructive pulmonary disease","volume":"19","author":"Shin","year":"2018","journal-title":"Respir Res"},{"key":"2024102102313134000_59.1.2004590.78","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1164\/rccm.201708-1684LE","article-title":"Blood eosinophilia neither reflects tissue eosinophils nor worsens clinical outcomes in chronic obstructive pulmonary disease","volume":"197","author":"Turato","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102102313134000_59.1.2004590.79","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jaip.2017.10.004","article-title":"Relationship of blood eosinophil count to exacerbations in chronic obstructive pulmonary disease","volume":"6","author":"Zeiger","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102102313134000_59.1.2004590.80","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.2147\/COPD.S147261","article-title":"Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker","volume":"12","author":"Acart\u00fcrk Tun\u00e7ay","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024102102313134000_59.1.2004590.81","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S2213-2600(17)30432-0","article-title":"Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort","volume":"5","author":"Hastie","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2024102102313134000_59.1.2004590.82","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00761-2017"},{"key":"2024102102313134000_59.1.2004590.83","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2147\/COPD.S120445","article-title":"Factors associated with plasma IL-33 levels in patients with chronic obstructive pulmonary disease","volume":"12","author":"Kim","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024102102313134000_59.1.2004590.84","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.2147\/COPD.S133859","article-title":"Prevalence and characteristics of asthma-COPD overlap syndrome identified by a stepwise approach","volume":"12","author":"Inoue","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024102102313134000_59.1.2004590.85","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.2147\/COPD.S129321","article-title":"Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD","volume":"12","author":"Song","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024102102313134000_59.1.2004590.86","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2147\/COPD.S113647","article-title":"Inflammatory biomarkers in asthma-COPD overlap syndrome","volume":"11","author":"Kobayashi","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024102102313134000_59.1.2004590.87","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1164\/rccm.201602-0353OC","article-title":"Asthma-like features and clinical course of chronic obstructive pulmonary disease. An analysis from the Hokkaido COPD Cohort Study","volume":"194","author":"Suzuki","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102102313134000_59.1.2004590.88","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2017-210531"},{"key":"2024102102313134000_59.1.2004590.89","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.jaip.2018.03.008","article-title":"Relationship of inhaled corticosteroid adherence to asthma exacerbations in patients with moderate-to-severe asthma","volume":"6","author":"Papi","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102102313134000_59.1.2004590.90","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jaip.2016.11.007","article-title":"Identifying risk of future asthma attacks using UK medical record data: a respiratory effectiveness group initiative","volume":"5","author":"Blakey","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102102313134000_59.1.2004590.91","first-page":"85","article-title":"Clinical and economic burden of elevated blood eosinophils in patients with and without uncontrolled asthma","volume":"23","author":"Casciano","year":"2017","journal-title":"J Manag Care Spec Pharm"},{"key":"2024102102313134000_59.1.2004590.92","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1513\/AnnalsATS.201606-463OC","article-title":"Sinus computed tomographic findings in adult smokers and nonsmokers with asthma. Analysis of clinical indices and biomarkers","volume":"14","author":"Kimura","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"2024102102313134000_59.1.2004590.93","doi-asserted-by":"crossref","first-page":"238","DOI":"10.18176\/jiaci.0128","article-title":"Asthma exacerbations in a tertiary hospital: clinical features, triggers, and risk factors for hospitalization","volume":"27","author":"Pola-Bibian","year":"2017","journal-title":"J Investig Allergol Clinical Immunol"},{"key":"2024102102313134000_59.1.2004590.94","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jaip.2016.07.015","article-title":"Blood eosinophil count and outcomes in severe uncontrolled asthma: a prospective study","volume":"5","author":"Zeiger","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102102313134000_59.1.2004590.95","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12890-016-0271-8","article-title":"Value of peripheral blood eosinophil markers to predict severity of asthma","volume":"16","author":"Casciano","year":"2016","journal-title":"BMC Pulm Med"},{"key":"2024102102313134000_59.1.2004590.96","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00100-2015"},{"key":"2024102102313134000_59.1.2004590.97","first-page":"1","article-title":"Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice","volume":"9","author":"Price","year":"2016","journal-title":"J Asthma Allergy"},{"key":"2024102102313134000_59.1.2004590.98","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S2213-2600(15)00367-7","article-title":"Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study","volume":"3","author":"Price","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2024102102313134000_59.1.2004590.99","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2014.04.011"},{"key":"2024102102313134000_59.1.2004590.100","doi-asserted-by":"publisher","DOI":"10.1111\/all.12136"},{"key":"2024102102313134000_59.1.2004590.101","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.03.044"},{"key":"2024102102313134000_59.1.2004590.102","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.jaip.2018.10.016","article-title":"The Severe Asthma Network in Italy: findings and perspectives","volume":"7","author":"Heffler","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102102313134000_59.1.2004590.103","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13223-018-0241-1","article-title":"Severe, eosinophilic asthma in primary care in Canada: a longitudinal study of the clinical burden and economic impact based on linked electronic medical record data","volume":"14","author":"Husereau","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"key":"2024102102313134000_59.1.2004590.104","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.jaci.2017.07.014","article-title":"More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II","volume":"141","author":"Chipps","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2024102102313134000_59.1.2004590.105","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jaip.2016.12.023","article-title":"Burden of chronic oral corticosteroid use by adults with persistent asthma","volume":"5","author":"Zeiger","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102102313134000_59.1.2004590.106","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2014.10.007"},{"key":"2024102102313134000_59.1.2004590.107","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.2147\/COPD.S170995","article-title":"Burden of disease associated with a COPD eosinophilic phenotype","volume":"13","author":"Ortega","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024102102313134000_59.1.2004590.108","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaip.2015.10.002","article-title":"Characteristics and outcomes of HEDIS-defined asthma patients with COPD diagnostic coding","volume":"4","author":"Zeiger","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102102313134000_59.1.2004590.109","doi-asserted-by":"crossref","first-page":"169","DOI":"10.11604\/pamj.2018.29.169.13042","article-title":"Establishment of the hematology reference intervals in a healthy population of adults in the Northwest of Morocco (Tangier-Tetouan region)","volume":"29","author":"Bakrim","year":"2018","journal-title":"Pan Afr Med J"},{"key":"2024102102313134000_59.1.2004590.110","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2018.09.036"},{"key":"2024102102313134000_59.1.2004590.111","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.rmed.2018.07.011","article-title":"Systemic inflammatory markers in relation to lung function in NHANES. 2007-2010","volume":"142","author":"Nerpin","year":"2018","journal-title":"Respir Med"},{"key":"2024102102313134000_59.1.2004590.112","doi-asserted-by":"crossref","first-page":"e0198444","DOI":"10.1371\/journal.pone.0198444","article-title":"Complete blood count reference intervals from a healthy adult urban population in Kenya","volume":"13","author":"Omuse","year":"2018","journal-title":"PLoS One"},{"key":"2024102102313134000_59.1.2004590.113","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/ijlh.12843","article-title":"Establishment of new complete blood count reference values for healthy Thai adults","volume":"40","author":"Wongkrajang","year":"2018","journal-title":"Int J Lab Hematol"},{"key":"2024102102313134000_59.1.2004590.114","doi-asserted-by":"crossref","first-page":"350","DOI":"10.11613\/BM.2017.038","article-title":"A nationwide multicentre study in Turkey for establishing reference intervals of haematological parameters with novel use of a panel of whole blood","volume":"27","author":"Ozarda","year":"2017","journal-title":"Biochem Med"},{"key":"2024102102313134000_59.1.2004590.115","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/cea.12669","article-title":"Both exhaled nitric oxide and blood eosinophil count were associated with mild allergic asthma only in non-smokers","volume":"46","author":"Giovannelli","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"2024102102313134000_59.1.2004590.116","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/all.12885","article-title":"Mouth breathing, another risk factor for asthma: the Nagahama Study","volume":"71","author":"Izuhara","year":"2016","journal-title":"Allergy"},{"key":"2024102102313134000_59.1.2004590.117","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2013-201687"},{"key":"2024102102313134000_59.1.2004590.118","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00130112"},{"key":"2024102102313134000_59.1.2004590.119","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00102110"},{"key":"2024102102313134000_59.1.2004590.120","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004401"},{"key":"2024102102313134000_59.1.2004590.121","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.02.019"},{"key":"2024102102313134000_59.1.2004590.122","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.09.022"},{"key":"2024102102313134000_59.1.2004590.123","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2018.02.031"},{"key":"2024102102313134000_59.1.2004590.124","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1080\/02770903.2018.1502301","article-title":"Effects of systemic corticosteroids on blood eosinophil counts in asthma: real-world data","volume":"56","author":"Ortega","year":"2019","journal-title":"J Asthma"},{"key":"2024102102313134000_59.1.2004590.125","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2015.240531"},{"key":"2024102102313134000_59.1.2004590.126","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.11.1.29-34.2004"},{"key":"2024102102313134000_59.1.2004590.127","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.jaip.2019.12.019","article-title":"Associations between individual characteristics and blood eosinophil counts in adults with asthma or COPD","volume":"8","author":"Caspard","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102102313134000_59.1.2004590.128","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.04101-2020"},{"key":"2024102102313134000_59.1.2004590.129","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-2600(19)30176-6","article-title":"Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial","volume":"7","author":"Sivapalan","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2024102102313134000_59.1.2004590.130","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2018.03.016"},{"key":"2024102102313134000_59.1.2004590.131","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.2174\/1389450119666180212120012","article-title":"Blood eosinophils as biomarkers to drive treatment choices in asthma and COPD","volume":"19","author":"Kostikas","year":"2018","journal-title":"Curr Drug Targets"},{"key":"2024102102313134000_59.1.2004590.132","doi-asserted-by":"crossref","first-page":"A111","DOI":"10.1136\/thoraxjnl-2015-207770.207","article-title":"Blood eosinophil counts in normal controls with no history of allergic disease","volume":"70","author":"Anand","year":"2015","journal-title":"Thorax"},{"key":"2024102102313134000_59.1.2004590.133","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/ATVBAHA.118.312338","article-title":"Smoking and increased white blood cells: a Mendelian randomization approach in the Copenhagen General Population Study","volume":"39","author":"Pedersen","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2024102102313134000_59.1.2004590.134","doi-asserted-by":"crossref","first-page":"113994","DOI":"10.1016\/j.bcp.2020.113994","article-title":"Predictors of a good response to inhaled corticosteroids in obesity-associated asthma","volume":"179","author":"Peerboom","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"2024102102313134000_59.1.2004590.135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.15586\/aei.v49i1.19","article-title":"Food allergy as an asthma comorbidity in children and adolescents: a practical approach through a real-world study","volume":"49","author":"Esteban-Gorgojo","year":"2021","journal-title":"Allergol Immunopathol"},{"key":"2024102102313134000_59.1.2004590.136","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S2213-2600(19)30195-X","article-title":"Blood eosinophils as a continuous variable in the treatment of COPD: impact on the guidelines","volume":"7","author":"van den Berge","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2024102102313134000_59.1.2004590.137","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jaip.2014.06.005","article-title":"High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma","volume":"2","author":"Zeiger","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102102313134000_59.1.2004590.138","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.chest.2018.07.002","article-title":"Predictors of asthma\/COPD overlap in FDNY firefighters with World Trade Center dust exposure: a longitudinal study","volume":"154","author":"Singh","year":"2018","journal-title":"Chest"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.04590-2020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:45:24Z","timestamp":1740357924000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.04590-2020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,25]]},"references-count":138,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,13]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1183\/13993003.04590-2020"],"URL":"https:\/\/doi.org\/10.1183\/13993003.04590-2020","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,25]]}}}